Pen Needles Market By Manufacturers, By Type (Standard Pen Needles, Safety Pen Needles) By Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), By Therapy (Insulin, GLP-1, Growth Hormone Therapy, Other), By Mode of Purchase (Retail, Non-retail), and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 391232 | Feb 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Global Pen Needles Market is valued USD 1.58 Billion in 2019 and is projected is to exhibit 10.56% CAGR during the forecast period. The market is projected to be around USD 3.19 Billion by 2026. The market is driven by the rapid increase in the development of connected IoT devices.
Pen needles use to transfer injectable medicines into the body. These devices include a deep needle with a plastic hub attached to the injection pens, which are of varying lengths and diameter. Injection pen and pen needles are an alternative drug delivery method to the traditional method.
Pen Needles Market Dynamics
The factors that increase the growth of the pen needles market are such as the growing prevalence of chronic diseases, high advancement in technology. Also, growing demand for pen devices for self-care diabetes management fosters the growth of the market Painless injections with pen needles and raising health awareness, is also driving the growth of this market. Moreover, the pen needles market is driven by an increase in the preference for pen needles over syringes and vials, growth in the geriatric population, and inclination toward minimally invasive procedures.
At the same time, modes of drug delivery, mental factors, and complications associated with the use of the needle, Poor healthcare reimbursement policies in developing as well as underdeveloped countries these factors may hamper the growth of the pen needles market. Furthermore, the high prevalence of diabetes and a rise in awareness among the diabetic population for easy delivery of drugs provide attractive opportunities for market growth.
Pen Needles Market Insight
Based on the region, North America is expected to dominate the market of a Pen Needles, due to rising diabetes prevalence, and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, growing market penetration by leading players, and the development of improved pen needle technologies.
Pen Needles Market Segmentation
The global Pen Needles Market is segmented into type, length, therapy, mode of purchase, and region. On the basis of the type the market is divided into standard pen needles, safety pen needles. Based on length the market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, 12mm. Based on therapy the market is segmented into insulin, GLP-1, growth hormone therapy, other. Based on mode of purchase the market is segmented into retail, and non-retail. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Pen Needles Market Competitive Landscape
The key players in Pen Needles Market are listed as Becton, Dickinson and Company, Novo Nordisk, Ulticare, Ypsomed Holding AG, B. Braun Melsungen AG, Terumo Corporation, Owen Mumford Ltd., Allison Medical, Cambridge Sensors Ltd., Montmed Inc., and Stat Medical Inc..
Pen needles use to transfer injectable medicines into the body. These devices include a deep needle with a plastic hub attached to the injection pens, which are of varying lengths and diameter. Injection pen and pen needles are an alternative drug delivery method to the traditional method.
Pen Needles Market Dynamics
The factors that increase the growth of the pen needles market are such as the growing prevalence of chronic diseases, high advancement in technology. Also, growing demand for pen devices for self-care diabetes management fosters the growth of the market Painless injections with pen needles and raising health awareness, is also driving the growth of this market. Moreover, the pen needles market is driven by an increase in the preference for pen needles over syringes and vials, growth in the geriatric population, and inclination toward minimally invasive procedures.
At the same time, modes of drug delivery, mental factors, and complications associated with the use of the needle, Poor healthcare reimbursement policies in developing as well as underdeveloped countries these factors may hamper the growth of the pen needles market. Furthermore, the high prevalence of diabetes and a rise in awareness among the diabetic population for easy delivery of drugs provide attractive opportunities for market growth.
Pen Needles Market Insight
Based on the region, North America is expected to dominate the market of a Pen Needles, due to rising diabetes prevalence, and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, growing market penetration by leading players, and the development of improved pen needle technologies.
Pen Needles Market Segmentation
The global Pen Needles Market is segmented into type, length, therapy, mode of purchase, and region. On the basis of the type the market is divided into standard pen needles, safety pen needles. Based on length the market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, 12mm. Based on therapy the market is segmented into insulin, GLP-1, growth hormone therapy, other. Based on mode of purchase the market is segmented into retail, and non-retail. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Pen Needles Market Competitive Landscape
The key players in Pen Needles Market are listed as Becton, Dickinson and Company, Novo Nordisk, Ulticare, Ypsomed Holding AG, B. Braun Melsungen AG, Terumo Corporation, Owen Mumford Ltd., Allison Medical, Cambridge Sensors Ltd., Montmed Inc., and Stat Medical Inc..
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Pen Needles Market, By Type
5.1. Pen Needles Market, By Type, 2018-2026
5.2. Standard Pen Needles
5.3. Safety Pen NeedlesChapter 6. Pen Needles Market, By Length
6.1. Pen Needles Market, by Length, 2018-2026
6.2. 4mm
6.3. 5mm
6.4. 6mm
6.5. 8mm
6.6. 10mm
6.7. 12mmChapter 7. Pen Needles Market, By Therapy
7.1. Pen Needles Market, By Therapy, 2018-2026
7.2. Insulin
7.3. GLP-1
7.4. Growth Hormone Therapy
7.5. OtherChapter 8. Pen Needles Market, By Mode of Purchase
8.1. Pen Needles Market, by Mode of Purchase, 2018-2026
8.2. Retail
8.3. Non-retailChapter 9. Pen Needles Market, By Region
9.1. Pen Needles Market, by Region, 2018-2026
9.1.1. North America
9.1.1.1. U.S
9.1.1.2. Rest of North America
9.1.2. Europe
9.1.2.1. U.K.
9.1.2.2. Germany
9.1.2.3. France
9.1.2.4. Rest of the Europe
9.1.3. Middle East & Africa (MEA)
9.1.3.1. GCC
9.1.3.2. North Africa
9.1.3.3. South Africa
9.1.3.4. Rest of MEA
9.1.4. Latin America (LATAM)
9.1.4.1. Brazil
9.1.4.2. Rest of LATAM
9.1.5. Asia Pacific (APAC)
9.1.5.1. India
9.1.5.2. China
9.1.5.3. Japan
9.1.5.4. Rest of the APACChapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning AnalysisChapter 11. Company Profiles11.1. Becton
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives11.2. Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives11.3. Novo Nordisk
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives11.4. Alcatel-Lucent
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives11.5 Ulticare
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives11.6. Ypsomed Holding AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives11.7. B. Braun Melsungen AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives11.8. Terumo Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives11.9. Owen Mumford Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives11.10. Allison Medical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives11.11. Cambridge Sensors Ltd.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives11.12. Montmed Inc.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives 11.13. Stat Medical Inc.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives11.14. List of other companies
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent InitiativesChapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Pen Needles Market, By Type
5.1. Pen Needles Market, By Type, 2018-2026
5.2. Standard Pen Needles
5.3. Safety Pen NeedlesChapter 6. Pen Needles Market, By Length
6.1. Pen Needles Market, by Length, 2018-2026
6.2. 4mm
6.3. 5mm
6.4. 6mm
6.5. 8mm
6.6. 10mm
6.7. 12mmChapter 7. Pen Needles Market, By Therapy
7.1. Pen Needles Market, By Therapy, 2018-2026
7.2. Insulin
7.3. GLP-1
7.4. Growth Hormone Therapy
7.5. OtherChapter 8. Pen Needles Market, By Mode of Purchase
8.1. Pen Needles Market, by Mode of Purchase, 2018-2026
8.2. Retail
8.3. Non-retailChapter 9. Pen Needles Market, By Region
9.1. Pen Needles Market, by Region, 2018-2026
9.1.1. North America
9.1.1.1. U.S
9.1.1.2. Rest of North America
9.1.2. Europe
9.1.2.1. U.K.
9.1.2.2. Germany
9.1.2.3. France
9.1.2.4. Rest of the Europe
9.1.3. Middle East & Africa (MEA)
9.1.3.1. GCC
9.1.3.2. North Africa
9.1.3.3. South Africa
9.1.3.4. Rest of MEA
9.1.4. Latin America (LATAM)
9.1.4.1. Brazil
9.1.4.2. Rest of LATAM
9.1.5. Asia Pacific (APAC)
9.1.5.1. India
9.1.5.2. China
9.1.5.3. Japan
9.1.5.4. Rest of the APACChapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning AnalysisChapter 11. Company Profiles11.1. Becton
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives11.2. Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives11.3. Novo Nordisk
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives11.4. Alcatel-Lucent
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives11.5 Ulticare
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives11.6. Ypsomed Holding AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives11.7. B. Braun Melsungen AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives11.8. Terumo Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives11.9. Owen Mumford Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives11.10. Allison Medical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives11.11. Cambridge Sensors Ltd.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives11.12. Montmed Inc.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives 11.13. Stat Medical Inc.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives11.14. List of other companies
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent InitiativesChapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Becton
Dickinson and Company
Novo Nordisk
Ulticare
Ypsomed Holding AG
B. Braun Melsungen AG
Terumo Corporation
Owen Mumford Ltd.
Allison Medical
Cambridge Sensors Ltd.
Montmed Inc.
Stat Medical Inc.
Other
Dickinson and Company
Novo Nordisk
Ulticare
Ypsomed Holding AG
B. Braun Melsungen AG
Terumo Corporation
Owen Mumford Ltd.
Allison Medical
Cambridge Sensors Ltd.
Montmed Inc.
Stat Medical Inc.
Other
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Connect With Us
+1-707-633-0404
sales@search4research.com